Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05

Fig. 1

Development of BCVA in patients with exsudative ARMD and (a) classic subtype, (b) occult subtype, and (c) in cases with subfoveal fluids without subtype differentiation. Grey area defines cases with visual acuity that have increased and exceeded 0.05 decimal acuity (Snellen letters, left side) or gone below 1.3 logMAR (right side) during follow-up. Due to equal values (ties), a random offset was added to these values to enhance visibility

Back to article page